Raymond James & Associates’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-27,216
| Closed | -$164K | – | 3700 |
|
2019
Q4 | $164K | Sell |
27,216
-54,884
| -67% | -$331K | ﹤0.01% | 3368 |
|
2019
Q3 | $296K | Buy |
82,100
+13,685
| +20% | +$49.3K | ﹤0.01% | 2998 |
|
2019
Q2 | $183K | Sell |
68,415
-7,000
| -9% | -$18.7K | ﹤0.01% | 3268 |
|
2019
Q1 | $223K | Buy |
75,415
+3,965
| +6% | +$11.7K | ﹤0.01% | 3154 |
|
2018
Q4 | $114K | Buy |
71,450
+7,400
| +12% | +$11.8K | ﹤0.01% | 3263 |
|
2018
Q3 | $236K | Buy |
64,050
+1,000
| +2% | +$3.69K | ﹤0.01% | 3172 |
|
2018
Q2 | $178K | Buy |
63,050
+200
| +0.3% | +$565 | ﹤0.01% | 3272 |
|
2018
Q1 | $233K | Sell |
62,850
-5,600
| -8% | -$20.8K | ﹤0.01% | 3039 |
|
2017
Q4 | $197K | Sell |
68,450
-19,000
| -22% | -$54.7K | ﹤0.01% | 3043 |
|
2017
Q3 | $393K | Sell |
87,450
-12,115
| -12% | -$54.4K | ﹤0.01% | 2613 |
|
2017
Q2 | $457K | Buy |
99,565
+2,100
| +2% | +$9.64K | ﹤0.01% | 2469 |
|
2017
Q1 | $410K | Sell |
97,465
-5,500
| -5% | -$23.1K | ﹤0.01% | 2504 |
|
2016
Q4 | $425K | Sell |
102,965
-9,000
| -8% | -$37.1K | ﹤0.01% | 2419 |
|
2016
Q3 | $907K | Buy |
111,965
+7,784
| +7% | +$63.1K | ﹤0.01% | 1946 |
|
2016
Q2 | $813K | Buy |
104,181
+5,181
| +5% | +$40.4K | ﹤0.01% | 1849 |
|
2016
Q1 | $764K | Sell |
99,000
-19,702
| -17% | -$152K | ﹤0.01% | 1810 |
|
2015
Q4 | $1.28M | Buy |
118,702
+6,552
| +6% | +$70.7K | ﹤0.01% | 1501 |
|
2015
Q3 | $775K | Sell |
112,150
-8,073
| -7% | -$55.8K | ﹤0.01% | 1726 |
|
2015
Q2 | $1.07M | Sell |
120,223
-2,477
| -2% | -$21.9K | ﹤0.01% | 1699 |
|
2015
Q1 | $1.21M | Buy |
122,700
+28,793
| +31% | +$284K | 0.01% | 1550 |
|
2014
Q4 | $1.15M | Buy |
93,907
+42,207
| +82% | +$517K | 0.01% | 1486 |
|
2014
Q3 | $516K | Sell |
51,700
-18,700
| -27% | -$187K | ﹤0.01% | 1839 |
|
2014
Q2 | $533K | Sell |
70,400
-75,600
| -52% | -$572K | ﹤0.01% | 1810 |
|
2014
Q1 | $480K | Buy |
+146,000
| New | +$480K | ﹤0.01% | 1803 |
|